AstraZeneca shares owned by Roble, Belko & Company
Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by Roble, Belko & Company
from 13F filings
Historical chart of Roble, Belko & Company investment in AstraZeneca
Tip: Access up to 7 years of quarterly data
All positions including AstraZeneca held by Roble, Belko & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in AstraZeneca by Roble, Belko & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24k | 314 | 76.43 |
| 2025-06-30 | $22k | 314 | 70.06 |
| 2025-03-31 | $23k | 314 | 73.25 |
| 2024-12-31 | $21k | 314 | 66.88 |
| 2024-09-30 | $24k | 314 | 76.43 |
| 2024-03-31 | $21k | 314 | 66.88 |
| 2023-12-31 | $21k | 314 | 66.88 |
| 2023-09-30 | $21k | 314 | 66.88 |
| 2023-06-30 | $22k | 314 | 70.06 |
| 2023-03-31 | $22k | 314 | 70.06 |
| 2022-12-31 | $57k | 834 | 68.35 |
| 2022-09-30 | $29k | 520 | 55.77 |
| 2022-06-30 | $34k | 520 | 65.38 |
| 2022-03-31 | $34k | 520 | 65.38 |
| 2021-12-31 | $30k | 520 | 57.69 |
| 2021-09-30 | $31k | 520 | 59.62 |
| 2021-06-30 | $31k | 520 | 59.62 |
| 2021-03-31 | $26k | 520 | 50.00 |
| 2020-12-31 | $26k | 520 | 50.00 |
| 2020-09-30 | $28k | 520 | 53.85 |
| 2020-06-30 | $28k | 520 | 53.85 |
| 2020-03-31 | $23k | 520 | 44.23 |
| 2019-12-31 | $26k | 520 | 50.00 |
| 2019-09-30 | $23k | 520 | 44.23 |
| 2019-06-30 | $21k | 520 | 40.38 |
| 2019-03-31 | $21k | 520 | 40.38 |
| 2018-12-31 | $20k | 520 | 38.46 |
| 2018-09-30 | $21k | 520 | 40.38 |
| 2018-06-30 | $18k | 520 | 34.62 |
| 2018-03-31 | $18k | 520 | 34.62 |
| 2017-12-31 | $18k | 520 | 34.62 |
| 2017-09-30 | $18k | 520 | 34.62 |
| 2017-06-30 | $18k | 520 | 34.62 |
| 2017-03-31 | $16k | 520 | 30.77 |
| 2016-12-31 | $14k | 520 | 26.92 |
| 2016-09-30 | $17k | 520 | 32.69 |
| 2016-06-30 | $16k | 520 | 30.77 |
| 2016-03-31 | $15k | 520 | 28.85 |
| 2015-12-31 | $18k | 520 | 34.62 |
| 2015-09-30 | $17k | 520 | 32.69 |
| 2015-06-30 | $17k | 260 | 65.38 |
| 2015-03-31 | $18k | 260 | 69.23 |